These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 1430081)

  • 1. Acute effects of testosterone infusion and naloxone on luteinizing hormone secretion in normal men.
    Kletter GB; Foster CM; Beitins IZ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1215-9. PubMed ID: 1430081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone does not reverse the suppressive effects of testosterone infusion on luteinizing hormone secretion in pubertal boys.
    Kletter GB; Foster CM; Brown MB; Padmanabhan V; Beitins IZ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1241-7. PubMed ID: 1955505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys.
    Kletter GB; Padmanabhan V; Beitins IZ; Marshall JC; Kelch RP; Foster CM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4010-4. PubMed ID: 9398704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocturnal naloxone fails to reverse the suppressive effects of testosterone infusion on luteinizing hormone secretion in pubertal boys.
    Kletter GB; Foster CM; Brown MB; Beitins IZ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1147-51. PubMed ID: 7962287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In pubertal girls, naloxone fails to reverse the suppression of luteinizing hormone secretion by estradiol.
    Cemeroglu AP; Kletter GB; Guo W; Brown MB; Kelch RP; Marshall JC; Padmanabhan V; Foster CM
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3501-6. PubMed ID: 9768654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone infusion reduces nocturnal luteinizing hormone pulse frequency in pubertal boys.
    Foster CM; Hassing JM; Mendes TM; Hale PM; Padmanabhan V; Hopwood NJ; Beitins IZ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1213-20. PubMed ID: 2685008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinizing hormone pulse characteristics in early pubertal boys are the same whether measured by radioimmuno- or immunofluorometric assay.
    Kletter GB; Padmanabhan V; Foster CM; Brown MB; Kelch RP; Beitins IZ
    J Clin Endocrinol Metab; 1993 May; 76(5):1173-6. PubMed ID: 8496308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased luteinizing hormone pulse frequency during sleep in early to midpubertal boys: effects of testosterone infusion.
    Hale PM; Khoury S; Foster CM; Beitins IZ; Hopwood NJ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1988 Apr; 66(4):785-91. PubMed ID: 3346356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muting of androgen negative feedback unveils impoverished gonadotropin-releasing hormone/luteinizing hormone secretory reactivity in healthy older men.
    Veldhuis JD; Zwart A; Mulligan T; Iranmanesh A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):529-35. PubMed ID: 11158004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.
    Finkelstein JS; Whitcomb RW; O'Dea LS; Longcope C; Schoenfeld DA; Crowley WF
    J Clin Endocrinol Metab; 1991 Sep; 73(3):609-20. PubMed ID: 1908484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poorly controlled type I diabetes mellitus in young men selectively suppresses luteinizing hormone secretory burst mass.
    López-Alvarenga JC; Zariñán T; Olivares A; González-Barranco J; Veldhuis JD; Ulloa-Aguirre A
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5507-15. PubMed ID: 12466346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary.
    Sheckter CB; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1989 Feb; 68(2):397-401. PubMed ID: 2493030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsatile intravenous infusion of recombinant human luteinizing hormone under acute gonadotropin-releasing hormone receptor blockade reconstitutes testosterone secretion in young men.
    Veldhuis JD; Iranmanesh A
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4474-9. PubMed ID: 15356050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitude.
    Iliff-Sizemore SA; Ortolano GA; Haisenleder DJ; Dalkin AC; Krueger KA; Marshall JC
    Endocrinology; 1990 Dec; 127(6):2876-83. PubMed ID: 1701131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of serum immunoreactive luteinizing hormone and bioactive follicle-stimulating hormone by testosterone in early pubertal boys.
    Hassing JM; Padmanabhan V; Kelch RP; Brown MB; Olton PR; Sonstein JS; Foster CM; Beitins IZ
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1082-9. PubMed ID: 2108181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men.
    Pitteloud N; Dwyer AA; DeCruz S; Lee H; Boepple PA; Crowley WF; Hayes FJ
    J Clin Endocrinol Metab; 2008 Mar; 93(3):784-91. PubMed ID: 18073301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis.
    Lanfranco F; Bonelli L; Baldi M; Me E; Broglio F; Ghigo E
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3633-9. PubMed ID: 18559917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
    Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
    J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.